Company Profile
Viva Biotech Holdings, an investment holding company provides structure-based drug discovery services to biotechnology and pharmaceutical customers globally. The company provides discovery biology services, including protein expression, structural biology, hit discovery, bioassay, biomolecular interaction, and pharmacology and DMPK.
Its portfolio also includes chemistry services, such as medicinal and synthetic chemistry, purification preparation, and computer-aided drug design services Offers chemical technology platforms, and antibody/biologics R&D services comprising recombinant protein expression platform, antibody discovery and affinity maturation, assay platform, antibody production and identification platform, and antigen-antibody structural resolution platform solutions
PROTAC/molecular glue services, including protein preparation and complex structure determination, ADME & PK/PD studies of PROTAC molecules, and XDC platforms, such as XDC conjugation and quality study, and XDC chemistry R&D. Additionally, it offers contract development and manufacturing services comprising integrated services for small molecule active pharmaceutical ingredients, formulation development and production services, and pharmaceutical analysis services, as well as CMC filing, global filing registration support, and services, as well as research services. Incorporated in 2008, the company is headquartered in Shanghai, China.